VEGFA and non-proliferative diabetic retinopathy: First-line treatment for severe NPDR includes regular intravitreal (IVT) injections with anti-vascular endothelial growth factor (anti-VEGF) therapies (Adamis et al., 2020; Simó and Hernández, 2022).